Higher organisms have evolved unusual molecular and genetic mechanisms to generate high affinity and highly specific antibodies to a seemingly infinite number of foreign antigens (([1][1])). Even though a highly diverse germline encoded antibody repertoire is created, most of the antibodies have low
No takes yet. Share an insight, caveat, or question.
Scharff et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: